AG˹ٷ

STOCK TITAN

[Form 4] Blue Bird Corporation Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Blue Bird Corp. (BLBD) Form 4 filing discloses that Chief Financial Officer Razvan Radulescu sold 10,000 common shares on 08/07/2025 at a weighted-average price of $53.21 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted on 08/12/2024, indicating it was pre-scheduled. Following the sale, the CFO directly holds 48,203 BLBD shares. No derivative securities were involved and no additional transactions were reported. The filing was signed by attorney-in-fact Matthew Meziere on 08/08/2025.

Blue Bird Corp. (BLBD) comunicazione Form 4 rivela che il Direttore Finanziario Razvan Radulescu ha venduto 10.000 azioni ordinarie il 07/08/2025 a un prezzo medio ponderato di 53,21 $ per azione. L'operazione è stata effettuata nell'ambito di un piano di trading Rule 10b5-1 adottato il 12/08/2024, segnalando che era programmata in anticipo. Dopo la vendita, il CFO detiene direttamente 48.203 azioni BLBD. Non sono stati coinvolti titoli derivati né segnalate ulteriori transazioni. La comunicazione è stata firmata dall’avvocato Matthew Meziere il 08/08/2025.

Presentación Formulario 4 de Blue Bird Corp. (BLBD) revela que el Director Financiero Razvan Radulescu vendió 10,000 acciones ordinarias el 07/08/2025 a un precio promedio ponderado de $53.21 por acción. La transacción se ejecutó bajo un plan de negociación Rule 10b5-1 adoptado el 12/08/2024, indicando que fue programada con anticipación. Tras la venta, el CFO posee directamente 48,203 acciones BLBD. No se involucraron valores derivados ni se reportaron transacciones adicionales. La presentación fue firmada por el apoderado Matthew Meziere el 08/08/2025.

Blue Bird Corp. (BLBD) Form 4 제출 내역� 따르� 최고재무책임�(Razvan Radulescu)가 2025� 8� 7일에 10,000� 보통�� 주당 가중평� 가� $53.21� 매도하였습니�. � 거래� 2024� 8� 12� 채택� Rule 10b5-1 거래 계획� 따라 사전� 예약� 것이었습니다. 매도 � CFO� 직접 48,203� BLBD 주식� 보유하고 있습니다. 파생상품은 포함되지 않았으며 추가 거래� 보고되지 않았습니�. � 서류� 2025� 8� 8� 대리인 Matthew Meziere� 의해 서명되었습니�.

Déclaration Formulaire 4 de Blue Bird Corp. (BLBD) révèle que le Directeur Financier Razvan Radulescu a vendu 10 000 actions ordinaires le 07/08/2025 au prix moyen pondéré de 53,21 $ par action. La transaction a été réalisée dans le cadre d’un plan de trading Rule 10b5-1 adopté le 12/08/2024, indiquant qu’elle était préprogrammée. Après la vente, le CFO détient directement 48 203 actions BLBD. Aucun titre dérivé n’a été impliqué et aucune transaction supplémentaire n’a été signalée. Le dépôt a été signé par le mandataire Matthew Meziere le 08/08/2025.

Blue Bird Corp. (BLBD) Form 4 Einreichung zeigt, dass der Finanzvorstand Razvan Radulescu am 07.08.2025 10.000 Stammaktien zu einem gewichteten Durchschnittspreis von 53,21 $ pro Aktie verkauft hat. Die Transaktion wurde im Rahmen eines am 12.08.2024 angenommenen Rule 10b5-1 Handelsplans durchgeführt, was auf eine vorherige Planung hinweist. Nach dem Verkauf hält der CFO direkt 48.203 BLBD-Aktien. Es waren keine Derivate beteiligt und es wurden keine weiteren Transaktionen gemeldet. Die Einreichung wurde am 08.08.2025 vom Bevollmächtigten Matthew Meziere unterzeichnet.

Positive
  • CFO retains 48,203 shares, maintaining significant equity alignment with shareholders.
  • Sale was executed under a Rule 10b5-1 plan, reducing concerns about opportunistic trading.
Negative
  • 10,000 shares sold by the CFO, signalling a decrease in direct ownership and potentially modest negative sentiment.

Insights

TL;DR: CFO sells 10k shares (~$0.53 M); modest insider outflow, plan-based, retains 48k shares.

The sale represents roughly US$0.53 million in proceeds at $53.21. While insider selling can signal reduced confidence, the use of a pre-arranged 10b5-1 plan limits informational concerns and suggests routine liquidity management. The CFO still owns 48,203 shares, preserving meaningful alignment with shareholders. Overall market impact should be modest, but investors may monitor future insider activity for trends.

TL;DR: Transaction is compliant and transparent; limited governance risk.

Filing details meet Section 16 requirements, indicating timely disclosure and proper attorney-in-fact authorization. Execution under a documented 10b5-1 plan reduces potential appearance of opportunistic trading, supporting governance best practices. No red flags such as undisclosed derivatives or group filings were noted.

Blue Bird Corp. (BLBD) comunicazione Form 4 rivela che il Direttore Finanziario Razvan Radulescu ha venduto 10.000 azioni ordinarie il 07/08/2025 a un prezzo medio ponderato di 53,21 $ per azione. L'operazione è stata effettuata nell'ambito di un piano di trading Rule 10b5-1 adottato il 12/08/2024, segnalando che era programmata in anticipo. Dopo la vendita, il CFO detiene direttamente 48.203 azioni BLBD. Non sono stati coinvolti titoli derivati né segnalate ulteriori transazioni. La comunicazione è stata firmata dall’avvocato Matthew Meziere il 08/08/2025.

Presentación Formulario 4 de Blue Bird Corp. (BLBD) revela que el Director Financiero Razvan Radulescu vendió 10,000 acciones ordinarias el 07/08/2025 a un precio promedio ponderado de $53.21 por acción. La transacción se ejecutó bajo un plan de negociación Rule 10b5-1 adoptado el 12/08/2024, indicando que fue programada con anticipación. Tras la venta, el CFO posee directamente 48,203 acciones BLBD. No se involucraron valores derivados ni se reportaron transacciones adicionales. La presentación fue firmada por el apoderado Matthew Meziere el 08/08/2025.

Blue Bird Corp. (BLBD) Form 4 제출 내역� 따르� 최고재무책임�(Razvan Radulescu)가 2025� 8� 7일에 10,000� 보통�� 주당 가중평� 가� $53.21� 매도하였습니�. � 거래� 2024� 8� 12� 채택� Rule 10b5-1 거래 계획� 따라 사전� 예약� 것이었습니다. 매도 � CFO� 직접 48,203� BLBD 주식� 보유하고 있습니다. 파생상품은 포함되지 않았으며 추가 거래� 보고되지 않았습니�. � 서류� 2025� 8� 8� 대리인 Matthew Meziere� 의해 서명되었습니�.

Déclaration Formulaire 4 de Blue Bird Corp. (BLBD) révèle que le Directeur Financier Razvan Radulescu a vendu 10 000 actions ordinaires le 07/08/2025 au prix moyen pondéré de 53,21 $ par action. La transaction a été réalisée dans le cadre d’un plan de trading Rule 10b5-1 adopté le 12/08/2024, indiquant qu’elle était préprogrammée. Après la vente, le CFO détient directement 48 203 actions BLBD. Aucun titre dérivé n’a été impliqué et aucune transaction supplémentaire n’a été signalée. Le dépôt a été signé par le mandataire Matthew Meziere le 08/08/2025.

Blue Bird Corp. (BLBD) Form 4 Einreichung zeigt, dass der Finanzvorstand Razvan Radulescu am 07.08.2025 10.000 Stammaktien zu einem gewichteten Durchschnittspreis von 53,21 $ pro Aktie verkauft hat. Die Transaktion wurde im Rahmen eines am 12.08.2024 angenommenen Rule 10b5-1 Handelsplans durchgeführt, was auf eine vorherige Planung hinweist. Nach dem Verkauf hält der CFO direkt 48.203 BLBD-Aktien. Es waren keine Derivate beteiligt und es wurden keine weiteren Transaktionen gemeldet. Die Einreichung wurde am 08.08.2025 vom Bevollmächtigten Matthew Meziere unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Radulescu Razvan

(Last) (First) (Middle)
3920 ARKWRIGHT ROAD
SUITE 200

(Street)
MACON GA 31210

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Blue Bird Corp [ BLBD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.0001 08/07/2025 S 10,000 D $53.21(1) 48,203 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price resulting from shares sold in multiple transactions on August 7, 2025, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024, at prices ranging from $52.17 to $54.37, inclusive. The reporting person undertakes to provide to Blue Bird Corporation, any security holder of Blue Bird Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Remarks:
/s/ Matthew Meziere as attorney-in-fact 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Blue Bird (BLBD) shares did the CFO sell?

10,000 common shares were sold.

What price did the BLBD shares sell for?

The weighted-average sale price was $53.21 per share.

When did the insider transaction occur?

The sale took place on 08/07/2025.

How many BLBD shares does the CFO own after the sale?

Razvan Radulescu now owns 48,203 shares directly.

Was the transaction executed under a Rule 10b5-1 plan?

Yes, the filing states it was pursuant to a 10b5-1 trading plan adopted on 08/12/2024.

What SEC form reports this insider activity?

The activity is disclosed on Form 4, filed on 08/08/2025.
Blue Bird

NASDAQ:BLBD

BLBD Rankings

BLBD Latest News

BLBD Latest SEC Filings

BLBD Stock Data

1.39B
31.31M
0.8%
119.4%
16.21%
Farm & Heavy Construction Machinery
Truck & Bus Bodies
United States
MACON